CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

Researchers at The University of Texas MD Anderson Cancer Center have identified molecular and cellular characteristics of anti-CD19 CAR T cell infusion products associated with how patients with large B-cell lymphoma (LBCL) respond to treatment and develop side effects.